UPDATE : Thursday, September 19, 2019
상단여백
Celltrion’s Remsima tops global sale of ₩1 trillion by Lee Han-soo 2018-11-23 14:54
Operating income declines at top 10 biotechs on KOSDAQ by Nam Doo-hyun 2018-11-22 11:15
Celltrion CEO involved in alleged ‘gapjil’ scandal by Lee Han-soo 2018-11-21 16:02
US data crucial for Korean biosimilars after success in Europe by Nam Doo-hyun 2018-11-21 15:29
FDA OKs sale of Celltrion's HIV biosimilar by Lee Han-soo 2018-11-21 12:57
라인
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug by So Jae-hyeon 2018-11-20 15:00
Celltrion Healthcare presents research results on using biosimilars in Europe by Lee Han-soo 2018-11-19 16:57
Bridge Bio applies for idiopathic pulmonary fibrosis treatment in US by Lee Han-soo 2018-11-19 11:58
Tego Science sales plunge in Q3 by Lee Han-soo 2018-11-16 14:54
NIBEC wins patent for novel peptide in US by Lee Han-soo 2018-11-16 14:40
라인
Samsung BioLogics fiasco hardly affects biotech stocks by Nam Doo-hyun 2018-11-16 11:30
Medipost mark profit losses in Q3 by Lee Han-soo 2018-11-15 15:18
[News Focus] Biotechs to suffer shocks from Samsung BioLogics mess by So Jae-hyeon 2018-11-15 14:56
Celltrion Healthcare posts ₩212.7 billion in Q3 sales by Lee Han-soo 2018-11-15 12:43
Regulators suspend trading of Samsung BioLogics on accounting fraud charges by Lee Han-soo 2018-11-14 18:28
라인
Alteogen promote antibody-drug conjugate cancer treatment in US by Lee Han-soo 2018-11-14 16:59
GCAM opens new plasma collection centers in US by Lee Han-soo 2018-11-09 17:58
GC launches Biocon’s antidiabetic biosimilar by Lee Han-soo 2018-11-08 15:46
'Biosimilar makers to benefit from new research accounting guideline' by Nam Doo-hyun 2018-11-07 11:23
Biois seeks KOSDAQ listing with ‘technology exception policy’ by So Jae-hyeon 2018-11-06 15:43
여백
여백
여백
Back to Top